988368
چهارشنبه 28 آذر 1403
دوره 15، شماره 3 - ( September 1396 )
جلد 15 شماره 3 صفحات 198-193 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Massah O, Effatpanah M, Shishehgar S. Matrix Model for Methamphetamine Dependence Among Iranian Female Methadone Patients: The First Report From the Most Populated Persian Gulf Country. Iranian Rehabilitation Journal 2017; 15 (3) :193-198
URL: http://irj.uswr.ac.ir/article-1-768-fa.html
URL: http://irj.uswr.ac.ir/article-1-768-fa.html
Matrix Model for Methamphetamine Dependence Among Iranian Female Methadone Patients: The First Report From the Most Populated Persian Gulf Country. مجله انگلیسی زبان توانبخشی. 1396; 15 (3) :193-198
چکیده: (7392 مشاهده)
Objectives: Methamphetamine (MA) dependence is a new health problem among Iranian female methadone patients. In recent years, the Matrix Model (a sixteen-week psychosocial treatment) has been provided for treating MA dependence. However, the problems associated with this treatment in methadone services are not clear.
Methods: A qualitative study was conducted to explore the problems associated with providing the Matrix Model in methadone clinics. Overall, 42 women were individually interviewed in 12 methadone clinics in Tehran in October 2015. All clinics provided the Matrix Model for MA dependence. Ten health professionals were also interviewed in three roundtable meetings. Data were analyzed using Atlas-ti software (version 9) based on the Grounded Theory of Strauss and Corbin.
Results: The mean age of the women was 34 years old. All of them were MA-dependent on the methadone programme. The most important theme was that the Matrix Model was able to manage MA craving and relapse among women in methadone treatment services. However, the Matrix Model was long, expensive and needed intensive staff training. Furthermore, the coverage of the treatment was inadequate. Conducting brief psychosocial treatments was suggested to reduce these problems.
Discussion: The results indicated that the Matrix Model is effective for treating MA dependence. However, the long length of the treatment, lack of cost-effectiveness, and intensive staff training are significant problems associated with providing MA treatment. Further studies are suggested to evaluate the role of brief interventions in reducing these problems in methadone treatment services.
Methods: A qualitative study was conducted to explore the problems associated with providing the Matrix Model in methadone clinics. Overall, 42 women were individually interviewed in 12 methadone clinics in Tehran in October 2015. All clinics provided the Matrix Model for MA dependence. Ten health professionals were also interviewed in three roundtable meetings. Data were analyzed using Atlas-ti software (version 9) based on the Grounded Theory of Strauss and Corbin.
Results: The mean age of the women was 34 years old. All of them were MA-dependent on the methadone programme. The most important theme was that the Matrix Model was able to manage MA craving and relapse among women in methadone treatment services. However, the Matrix Model was long, expensive and needed intensive staff training. Furthermore, the coverage of the treatment was inadequate. Conducting brief psychosocial treatments was suggested to reduce these problems.
Discussion: The results indicated that the Matrix Model is effective for treating MA dependence. However, the long length of the treatment, lack of cost-effectiveness, and intensive staff training are significant problems associated with providing MA treatment. Further studies are suggested to evaluate the role of brief interventions in reducing these problems in methadone treatment services.
نوع مقاله: پژوهشي |
موضوع مقاله:
مطالعات اعتیاد
دریافت: 1395/11/30 | پذیرش: 1396/4/7 | انتشار: 1396/5/31
دریافت: 1395/11/30 | پذیرش: 1396/4/7 | انتشار: 1396/5/31
فهرست منابع
1. United Nations Office on Drugs and Crime. World drug report 2013. Vienna: United Nations Publications; 2013.
2. United Nations Office on Drugs and Crime. World drug report 2014. Vienna: United Nations Publications; 2014.
3. Mehrjerdi ZA. Crystal in Iran: Methamphetamine or heroin kerack. DARU Journal of Pharmaceutical Sciences. 2013; 21(1):22. doi: 10.1186/2008-2231-21-22 [DOI:10.1186/2008-2231-21-22]
4. Alam mehrjerdi Z, Barr AM, Noroozi A. Methamphetamine-associated psychosis: A new health challenge in Iran. DARU Journal of Pharmaceutical Sciences. 2013; 21(1):30. doi: 10.1186/2008-2231-21-30 [DOI:10.1186/2008-2231-21-30]
5. Alam Mehrjerdi Z, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine injecting treatment seekers: The first report from Iran. International Journal of STD & AIDS. 2013; 25(6):420–7. doi: 10.1177/0956462413512806 [DOI:10.1177/0956462413512806]
6. Yoonessi A, Ekhtiari H. Text messages as a tool for assessing public concern about drug problems. International Journal of Drug Policy. 2013; 24(6):624–7. doi: 10.1016/j.drugpo.2013.06.002 [DOI:10.1016/j.drugpo.2013.06.002]
7. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: An emerging problem in the drug addiction treatment network in Iran. International Journal of Drug Policy. 2013; 24(6):115–6. doi: 10.1016/j.drugpo.2013.05.003 [DOI:10.1016/j.drugpo.2013.05.003]
8. Alaee A, Zarghami M, Farnia S, Khademloo M, Khoddad T. Comparison of brain white matter hyperintensities in methamphetamine and methadone dependent patients and healthy controls. Iranian Journal of Radiology. 2014; 11(2):14275.. doi: 10.5812/iranjradiol.14275 [DOI:10.5812/iranjradiol.14275]
9. Ahmadi Jouibari T, Fattahi N, Shamsipur M. Rapid extraction and determination of amphetamines in human urine samples using dispersive liquid liquid microextraction and solidification of floating organic drop followed by high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 2014; 94(6):145–51. doi: 10.1016/j.jpba.2014.01.044 [DOI:10.1016/j.jpba.2014.01.044]
10. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014; 87:150–60. doi: 10.1016/j.neuropharm.2014.04.002 [DOI:10.1016/j.neuropharm.2014.04.002]
11. Lee N, Rawson R. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Review. 2008; 27(3):309–17. doi: 10.1080/09595230801919494 [DOI:10.1080/09595230801919494]
12. Huber A, Ling W, Shoptaw S, Gulati V, Brethen P, Rawson R. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases. 1997; 16(4):41–50. doi: 10.1080/10550889709511142 [DOI:10.1080/10550889709511142]
13. Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli Casey PJ, et al. An intensive outpatient approach for cocaine abuse treatment. Journal of Substance Abuse Treatment. 1995; 12(2):117–27. doi: 10.1016/0740-5472(94)00080-b [DOI:10.1016/0740-5472(94)00080-B]
14. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry. 2002; 59(9):817. doi: 10.1001/archpsyc.59.9.817 [DOI:10.1001/archpsyc.59.9.817]
15. Strauss A, Corbin J. Basics of qualitative research: Grounded theory procedures and techniques. California: Sage Publications; 1991.
16. Pope C, Mays N. Qualitative research: Reaching the parts other methods cannot reach: An introduction to qualitative methods in health and health services research. BMJ. 1995; 311(6996):42–5. doi: 10.1136/bmj.311.6996.42 [DOI:10.1136/bmj.311.6996.42]
17. Baker A, Boggs TG, Lewin TJ. Randomized controlled trial of brief cognitive behavioural interventions among regular users of amphetamine. Addiction. 2001; 96(9):1279–87. doi: 10.1046/j.1360-0443.2001.96912797.x [DOI:10.1046/j.1360-0443.2001.96912797.x]
18. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction. 2005; 100(3):367–78. doi: 10.1111/j.1360-0443.2005.01002.x [DOI:10.1111/j.1360-0443.2005.01002.x]
19. Simpson JL, Grant KM, Daly PM, Kelley SG, Carlo G, Bevins RA. Psychological burden and gender differences in methamphetamine dependent individuals in treatment. Journal of Psychoactive Drugs. 2016; 48(4):261–9. doi: 10.1080/02791072.2016.1213470 [DOI:10.1080/02791072.2016.1213470]
20. Han Y, Lin V, Wu F, Hser Y-I. Gender comparisons among Asian American and Pacific Islander patients in drug dependency treatment. Substance Use & Misuse. 2016; 51(6):752–62. doi: 10.3109/10826084.2016.1155604 [DOI:10.3109/10826084.2016.1155604]
